Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan;15(1):26-35.
doi: 10.1111/j.1542-474X.2009.00336.x.

The time course of new T-wave ECG descriptors following single- and double-dose administration of sotalol in healthy subjects

Affiliations

The time course of new T-wave ECG descriptors following single- and double-dose administration of sotalol in healthy subjects

Fabrice Extramiana et al. Ann Noninvasive Electrocardiol. 2010 Jan.

Abstract

Introduction: The aim of the study was to assess the time course effect of IKr blockade on ECG biomarkers of ventricular repolarization and to evaluate the accuracy of a fully automatic approach for QT duration evaluation.

Methods: Twelve-lead digital ECG Holter was recorded in 38 healthy subjects (27 males, mean age = 27.4 + or - 8.0 years) on baseline conditions (day 0) and after administration of 160 mg (day 1) and 320 mg (day 2) of d-l sotalol. For each 24-hour period and each subject, ECGs were extracted every 10 minutes during the 4-hour period following drug dosage. Ventricular repolarization was characterized using three biomarker categories: conventional ECG time intervals, principal component analysis (PCA) analysis on the T wave, and fully automatic biomarkers computed from a mathematical model of the T wave.

Results: QT interval was significantly prolonged starting 1 hour 20 minutes after drug dosing with 160 mg and 1 hour 10 minutes after drug dosing with 320 mg. PCA ventricular repolarization parameters sotalol-induced changes were delayed (>3 hours). After sotalol dosing, the early phase of the T wave changed earlier than the late phase prolongation. Globally, the modeled surrogate QT paralleled manual QT changes. The duration of manual QT and automatic surrogate QT were strongly correlated (R(2) = 0.92, P < 0.001). The Bland and Altman plot revealed a nonstationary systematic bias (bias = 26.5 ms + or - 1.96*SD = 16 ms).

Conclusions: Changes in different ECG biomarkers of ventricular repolarization display different kinetics after administration of a potent potassium channel blocker. These differences need to be taken into account when designing ventricular repolarization ECG studies.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Study design and time points for ECG extraction. (B) Biomarker categories: (1) manual cursors are set for both conventional ECG time intervals and markers derived from a PCA analysis on the T wave, (2) fully automatic biomarkers computation from the bi‐Gaussian function (BGF) model. (C) Left part: standard eight‐lead ECG change to PCA eight‐lead transformation. Right part: Bi‐Gaussian function model of the T wave.
Figure 2
Figure 2
Upper panel: time course of sotalol concentration after single‐dose administration (160 mg). Lower panels: sotalol effects on ventricular repolarization biomarkers expressed as a percentage change relative to the baseline period. H0 to H4: time after sotalol administration in hours (H).
Figure 3
Figure 3
Panel A: relationship between manual QT interval (x‐axis) and the automatic QT interval (y‐axis). Panel B: Bland and Altman plot of manually and automatically measured QT interval duration.
Figure 4
Figure 4
Upper panel: relationship between RR interval (x‐axis) and T‐wave amplitude (y‐axis). Lower panel: Drug's effects expressed as a percentage change relative to the baseline period on RR interval and T‐wave amplitude after sotalol 160 mg and 320 mg administration. H0 to H4: time after sotalol administration in hours (H).

Similar articles

Cited by

References

    1. Crouch MA, Limon L, Cassano AT. Clinical relevance and management of drug‐related QT interval prolongation. Pharmacotherapy 2003;23:881–908. - PubMed
    1. Ray WA, Murray KT, Meredith S, et al Oral erythromycin and the risk of sudden death from cardiac causes. N Engl J Med 2004;351:1089–1096. - PubMed
    1. Curtis LH, Ostbye T, Sendersky V, et al Prescription of QT‐prolonging drugs in a cohort of about 5 million outpatients. Am J Med 2003;114:135–141. - PubMed
    1. International Conference on Harmonisation (ICH): The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non‐antiarrhythmic drugs. http://www.fda.gov/cder/guidance/6922fnl.pdf last accessed August 21st 2008. - PubMed
    1. Redfern WS, Carlsson L, Davis AS, et al Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development. Cardiovasc Res 2003;58:32–45. - PubMed

MeSH terms